中文 | English
Return
Total: 4 , 1/1
Show Home Prev Next End page: GO
MeSH:(Palivizumab/*therapeutic use)

1.Prevention of respiratory syncytial viral infections in late preterm infants.

Koravangattu SANKARAN ; Mila KALAPPURACKAL ; Ben TAN

Chinese Journal of Contemporary Pediatrics 2013;15(4):241-248

2.Children hospitalized with respiratory syncytial virus infection in Saskatchewan pediatric tertiary care centers, 2002-2005.

Ayisha KURJI ; Ben TAN ; Jaya BODANI ; Bonnie JANZEN ; Athena MCCONNELL ; Rachana BODANI ; Derek RAJAKUMAR ; Anil SHARMA ; Koravangattu SANKARAN

Chinese Journal of Contemporary Pediatrics 2014;16(10):1005-1013

3.Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia.

Young Mi HAN ; Hyun Joo SEO ; Seo Heui CHOI ; Yu Jin JUNG ; So Yoon AHN ; Hye Soo YOO ; Se In SUNG ; Jae Won SHIM ; Yeon Kyung LEE ; Sun Young KO ; Son Moon SHIN ; Jong Hee HWANG ; Jang Hoon LEE ; Byung Min CHOI ; Eun Sun KIM ; Ji Hyun JEON ; Sung Shin KIM ; Yun Sil CHANG ; Won Soon PARK

Journal of Korean Medical Science 2015;30(7):924-931

4.Respiratory Syncytial Virus Related Readmission in Preterm Infants Less than 34 weeks' Gestation Following Discharge from a Neonatal Intensive Care Unit in Korea.

Jang Hoon LEE ; Chun Soo KIM ; Yun Sil CHANG ; Jung Hwan CHOI

Journal of Korean Medical Science 2015;30(Suppl 1):S104-S110

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4 , 1/1 Show Home Prev Next End page: GO